Cargando…
miR-15b represses BACE1 expression in sporadic Alzheimer’s disease
Beta-site Amyloid precursor protein Cleaving Enzyme 1 (BACE1) is conceived as a potential target for therapies against Alzheimer disease (AD). MicroRNAs (miRNAs) are small non-coding RNAs that negatively regulate gene expression in a sequence-specific manner. Although miRNAs have been increasingly r...
Autores principales: | Gong, Guohua, An, Fengmao, Wang, Yu, Bian, Ming, Yu, Li-Jun, Wei, Chengxi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5710945/ https://www.ncbi.nlm.nih.gov/pubmed/29207665 http://dx.doi.org/10.18632/oncotarget.21177 |
Ejemplares similares
-
MiR-124 acts as a target for Alzheimer’s disease by regulating BACE1
por: An, Fengmao, et al.
Publicado: (2017) -
Correction: MiR-124 acts as a target for Alzheimer’s disease by regulating BACE1
por: An, Fengmao, et al.
Publicado: (2018) -
Anti-Inflammatory Activity of 4-(4-(Heptyloxy)phenyl)-2,4-dihydro-3H-1,2,4-triazol-3-one via Repression of MAPK/NF-κB Signaling Pathways in β-Amyloid-Induced Alzheimer’s Disease Models
por: An, Fengmao, et al.
Publicado: (2022) -
MiR-15b and miR-322 inhibit SETD3 expression to repress muscle cell differentiation
por: Zhao, Meng-Jie, et al.
Publicado: (2019) -
1,8-Cineole Ameliorates Advanced Glycation End Products-Induced Alzheimer’s Disease-like Pathology In Vitro and In Vivo
por: An, Fengmao, et al.
Publicado: (2022)